Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

NCT04820751 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Viral Pneumonia
Serotonin Syndrome
Platelet Dysfunction

Interventions

DRUG: Cyproheptadine Hydrochloride 4 MG

Sponsor

Ciusss de L'Est de l'Île de Montréal

Collaborators

[object Object]